Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wedzicha, J. A.
The Proceedings of the American Thoracic Society 1:115-120 (2004)
© 2004 The American Thoracic Society

Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease

Jadwiga A. Wedzicha

Academic Unit of Respiratory Medicine, St. Bartholomew's and Royal London School of Medicine and Dentistry, Dominion House, St. Bartholomew's Hospital, West Smithfield, London, United Kingdom

Correspondence and requests for reprints should be addressed to Jadwiga A. Wedzicha, M.D., Academic Unit of Respiratory Medicine, St. Bartholomew's and Royal London School of Medicine and Dentistry, Dominion House, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. E-mail: j.a.wedzicha{at}qmul.ac.uk

Exacerbations of chronic obstructive pulmonary disease (COPD) are a major cause of morbidity and mortality and hospital admission. Respiratory viral infections, especially rhinoviruses, are a major cause of COPD exacerbations, with upper respiratory tract infections being associated with over 50% of COPD exacerbations. The presence of an upper respiratory tract infection leads to a more severe exacerbation and a longer symptom recovery time at exacerbation. Respiratory viral infections occurring during COPD exacerbations are more likely to lead to hospitalization. Sputum inflammatory markers were found to be higher in those patients with symptoms of a common cold or where rhinovirus was detected at exacerbation, thus suggesting that viral infections lead to greater airway inflammation and thus more severe exacerbations. COPD exacerbations are associated also with systemic inflammatory effects with increases in markers such as plasma fibrinogen and interleukin-6. Respiratory viruses have also been detected when the patients are stable, and this suggests that chronic viral infection may occur. Strategies to prevent viral infection will have a significant effect on the morbidity of COPD and will improve quality of life.

Key Words: respiratory viruses • chronic obstructive pulmonary diseases • exacerbations




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
N. MacIntyre and Y. C. Huang
Acute Exacerbations and Respiratory Failure in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 530 - 535.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Manolov, T. T. Tan, A. Forsgren, and K. Riesbeck
Moraxella-Dependent {alpha}1-Antichymotrypsin Neutralization: A Unique Virulence Mechanism
Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 609 - 617.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. W. S. Ko, M. Ip, P. K. S. Chan, M. C. H. Chan, K.-W. To, S. S. S. Ng, S. S. L. Chau, J. W. Tang, and D. S. C. Hui
Viral Etiology of Acute Exacerbations of COPD in Hong Kong
Chest, September 1, 2007; 132(3): 900 - 908.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Neff-LaFord, S. Teske, T. P. Bushnell, and B. P. Lawrence
Aryl Hydrocarbon Receptor Activation during Influenza Virus Infection Unveils a Novel Pathway of IFN-{gamma} Production by Phagocytic Cells
J. Immunol., July 1, 2007; 179(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
B. R. Celli and P. J. Barnes
Exacerbations of chronic obstructive pulmonary disease
Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. R WALT, T. M BLICHARZ, R. B HAYMAN, D. M RISSIN, M. BOWDEN, W. L SIQUEIRA, E. J HELMERHORST, N. GRAND-PIERRE, F. G OPPENHEIM, J. S BHATIA, et al.
Microsensor Arrays for Saliva Diagnostics
Ann. N.Y. Acad. Sci., March 1, 2007; 1098(1): 389 - 400.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. W.S. Ko, M. Ip, P. K.S. Chan, J. P.C. Fok, M. C.H. Chan, J. C. Ngai, D. P.S. Chan, and D. S.C. Hui
A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPD
Chest, January 1, 2007; 131(1): 44 - 52.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. H. Randell
Airway Epithelial Stem Cells and the Pathophysiology of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2006; 3(8): 718 - 725.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
U. S. Sajjan, Y. Jia, D. C. Newcomb, J. K. Bentley, N. W. Lukacs, J. J. LiPuma, and M. B. Hershenson
H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression
FASEB J, October 1, 2006; 20(12): 2121 - 2123.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Punturieri, P. Copper, T. Polak, P. J. Christensen, and J. L. Curtis
Conserved Nontypeable Haemophilus influenzae-Derived TLR2-Binding Lipopeptides Synergize with IFN-beta to Increase Cytokine Production by Resident Murine and Human Alveolar Macrophages
J. Immunol., July 1, 2006; 177(1): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
E Hak, M. Rovers, M. Kuyvenhoven, F. Schellevis, and T. Verheij
Incidence of GP-diagnosed respiratory tract infections according to age, gender and high-risk co-morbidity: the Second Dutch National Survey of General Practice
Fam. Pract., June 1, 2006; 23(3): 291 - 294.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. I. Restrepo and A. Anzueto
Guidelines for the diagnoses and treatment of adult lower respiratory tract infections: a true "European cooperative effort"
Eur. Respir. J., December 1, 2005; 26(6): 979 - 981.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. P. Schleimer
Innate Immune Responses and Chronic Obstructive Pulmonary Disease: "Terminator" or "Terminator 2"?
Proceedings of the ATS, November 1, 2005; 2(4): 342 - 346.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. B. Greenberg
Respiratory Viral Infections in High-Risk Patients
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1142 - 1143.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
C. Pilette, S. R. Durham, J.-P. Vaerman, and Y. Sibille
Mucosal Immunity in Asthma and Chronic Obstructive Pulmonary Disease: A Role for Immunoglobulin A?
Proceedings of the ATS, April 1, 2004; 1(2): 125 - 135.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. Buhl and S. G. Farmer
Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma
Proceedings of the ATS, April 1, 2004; 1(2): 136 - 142.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Thoracic Society.